PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97825090 |
Filing Date: 03/06/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97825090 |
---|---|
MARK INFORMATION | |
*MARK | Zelmetico |
STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | Zelmetico |
MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | DAIICHI SANKYO COMPANY, LIMITED |
*MAILING ADDRESS | 3-5-1, Nihonbashi Honcho, Chuo-ku |
*CITY | Tokyo |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | Japan |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
103-8426 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Japan |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment and prevention of cancer, oncological diseases, leukemia, musculoskeletal disorders, muscular dystrophy, pseudoxanthoma, dermatological disorders, allergy, cardiovascular diseases, kidney diseases, fibrodysplasia ossificans progressive, systemic lupus erythematosus, Netherton syndrome; Vaccines |
FILING BASIS | SECTION 44(e) |
FOREIGN REGISTRATION NUMBER |
5908098 |
FOREIGN REGISTRATION COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
Japan |
FOREIGN REGISTRATION DATE |
12/22/2016 |
FOREIGN REGISTRATION EXPIRATION DATE |
12/22/2026 |
FOREIGN REGISTRATION FILE NAME(S) | |
ORIGINAL PDF FILE | reg-19821116034-172159831 _._JP_Certificate_and_tra nslation___Zelmetico.pdf |
CONVERTED PDF FILE(S) (2 pages) |
\\TICRS\EXPORT18\IMAGEOUT 18\978\250\97825090\xml1\ APP0003.JPG |
\\TICRS\EXPORT18\IMAGEOUT 18\978\250\97825090\xml1\ APP0004.JPG | |
STANDARD CHARACTERS OR EQUIVALENT |
YES |
ATTORNEY INFORMATION | |
NAME | Molly Hunsinger |
ATTORNEY DOCKET NUMBER | 3T23789006 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Ladas & Parry LLP |
STREET | 224 S. Michigan Ave., Ste. 1600 |
CITY | Chicago |
STATE | Illinois |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 60604 |
PHONE | 312-427-1300 |
EMAIL ADDRESS | CHIUSTM@LADAS.NET |
OTHER APPOINTED ATTORNEY | Boris Umansky, Burton S. Ehrlich, Richard J. Streit and David C. Brezina |
CORRESPONDENCE INFORMATION | |
NAME | Molly Hunsinger |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | CHIUSTM@LADAS.NET |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | mhunsinger@ladas.net |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 350 |
*TOTAL FEES PAID | 350 |
SIGNATURE INFORMATION | |
SIGNATURE | /Molly Hunsinger/ |
SIGNATORY'S NAME | Molly Hunsinger |
SIGNATORY'S POSITION | Attorney of Record, Illinois Bar Member |
SIGNATORY'S PHONE NUMBER | 312-427-1300 |
DATE SIGNED | 03/06/2023 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97825090 |
Filing Date: 03/06/2023 |
The applicant's current Correspondence Information: |
Molly Hunsinger |
PRIMARY EMAIL FOR CORRESPONDENCE: CHIUSTM@LADAS.NET SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mhunsinger@ladas.net Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|